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ABSTRACT 
 
 In modern agriculture, a great deal of time and resources are spent 
combating widespread insect infestation and microbial infections.  
Comprehension of the natural defenses against these threats could enable the 
production of genetically modified plants with enhanced innate immunity 
without the use of chemicals to which insects and microbes are renown for 
developing resistances to.  Plants have three main defense mechanisms to 
guard against bacteria: physical tissue barriers, basal defenses, and race-
specific resistance.  In the latter case, the plant cell perceives foreign proteins 
and this triggers the hypersensitive response (HR), a programmed cell death 
(PCD) to prevent further spread of the pathogen.  This is mediated by the 
recognition of specific avirulence (Avr) proteins from the pathogen by 
resistance (R) proteins in the plant.  A member of the evolutionarily conserved 
copine family, BONZAI 1 (BON 1) is a key regulator of defense responses in 
A. thaliana. BON1 has been shown to negatively regulate the R gene 
suppressor of npr1-1, constitutive 1 (SNC1).  In the Columbia (Col) accession 
of A. thaliana, the loss-of-function (LOF) bon1-1 mutant allele exhibits a 
growth defect phenotype (dwarfed plant).  bon1-1 leads to constitutive 
activation of SNC1 which compromises normal plant growth.  BON1 has been 
shown to interact with two other proteins: BON1-associated protein 1 and 2 
(BAP1, BAP2).  The molecular link(s) between BON1 and BAP, and their 
negative regulation of plant defenses are not well understood.  We report the 
identification and characterization of a new component in the BON1 regulatory 
pathway and our efforts in probing the biochemical activities of BAP2 in 
regulating defense responses. 
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CHAPTER 1:
General Introduction
 As static organisms, competitive adaptability  of plants to biotic and 
abiotic factors is essential to their continued survival.  One adaptable feature 
of particular interest, bearing applications to possibly  improving agriculture, is 
plant innate immunity to microorganisms.  Comprehension of this system is 
valuable to improving agricultural output in a world experiencing a dramatic 
increase of insects and microbes resistant to chemical control.  
 Many species of pathogens attempt to colonize the leaf apoplast and 
circumvent host defenses by secreting proteins, referred to as “effectors”, 
which are highly evolved to facilitate this process, thus conveying virulence 
(2).  In a “compatible” pathogen-plant interaction, the pathogen is able to infect 
the plant and circumvent defenses without eliciting host defense responses 
(36).  However, in the “incompatible” scenario, the effectors or pathogen-
associated molecular patterns (PAMPs) are recognized (13).  PAMPs include 
compounds such as flagellar proteins (flg22), bacterial translation factor (EF-
Tu), chitin, and cell wall lipopolysaccharides that are indicative of bacteria and 
fungi (16, 21, 30, 48, 47). When PAMPs have been detected, some effectors 
such as HopAB2 and AvrPto can counteract by deactivating basal defenses by 
targeting specific host proteins in the signaling pathway  (16).  Plant defenses 
have coevolved to recognize such virulence factors, henceforth the recognized 
effectors are termed “avirulence” (Avr) proteins. Basal defenses are activated 
upon recognition of PAMPs, however, when plant resistance (R) proteins 
detect the presence of Avr proteins they initiate defense responses in the form 
of a hypersensitive response (HR) (13). HR enables the plant to survive by 
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rapidly stemming the spread of the infection.  The HR is characterized by a 
number of events including: transcriptional reprogramming, rapid ion fluxes, 
extracellular oxidative burst, and programmed cell death (PCD) both within the 
site of infection and the surrounding tissues (9, 13, 22, 23, 29, 31, 34). 
Activation of PCD often results in the appearance of necrotic lesions. In the 
absence of a pathogen, PCD is an essential component in the growth of 
multicellular organisms, defining their size, shape, and general morphology 
(23, 43).  The R gene to Avr gene interaction is usually  allele-specific thus a 
“gene-for-gene” model was proposed.  Thus, in order for a plant to detect a 
given Avr protein, it must have the corresponding R gene to code for the R 
protein that will specifically bind to a given Avr.  Very often, this recognition 
leads to the activation of mitogen-activated protein kinase (MAPK) cascades 
(31), which in turn can signal the activation of defense-related genes. The R 
protein Pto, which conveys “race-specific resistance to P. syringae” (43), was 
the first cloned plant example of gene-for-gene resistance (27, 33).  Another 
well-studied example is RSR-1, which has been proposed to directly recognize 
the R. solanacearum effector protein popP2 and then activate plant defense-
Figure 1.1. R protein structures and 
functional domains. 
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related genes (10). 
 However, it unlikely that all Avr/R gene interactions function in this one-
on-one manner; there are thousands of different effector proteins in many 
different species of pathogens whereas there are only a few hundred known R 
genes in plants.  In addition, pathogens have generation time far shorter than 
that of their hosts, therefore can evolve more quickly.  To address this 
anomaly, it has been suggested in the “Guard Hypothesis” that some R 
proteins may monitor or “guard” certain endogenous plant proteins whose 
function may be modulated by Avr proteins  (4, 8, 9, 19, 20, 28, 40).   The R 
proteins may be sensitive to chemical changes, such as phosphorylation, 
acetylation, or proteolytic cleavage of their guarded proteins and then signal 
defense pathways without direct detection of the invading Avr protein (8, 20, 
28).  It is logical that R proteins could be involved in multiprotein recognition 
complexes capable of recognizing a wide variety of avirulence factors.  The 
RIN4 host protein provides strong evidence in support of the second model. 
Two proteins have been found to guard RIN4: RPS2 and RPM1 (3, 4, 26). 
When RIN4 has been either phosphorylated or cleaved by Avr proteins, RPS2 
and RPM1 perceive such chemical changes and activate defense responses. 
Functional RIN4 negatively regulates these two proteins, thus preventing 
inappropriate activation of defense responses in the absence of a pathogen. 
This regulation is critical to plant survival as the rin4 loss-of-function (LOF) 
mutant is lethal (4). This lethality has been attributed to the constitutive 
activation of RPS2, because the rin4rps2 double mutant rescues the lethality 
of rin4.R proteins have important structural features enabling them to localize 
within the cell and carry  out their biochemical functions.  There are five major 
classes of R proteins, which have been grouped by their functional domains 
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(9). Some of these domains include a nucleotide-binding site (NBS) and 
leucine-rich repeats (LRR).  For example, class 2 R proteins are collectively 
known as CC-NBS-LRR due to a C-terminal coiled-coil (CC) domain (9) and 
class 3 R proteins possess an N-terminal toll-interleukin-like receptor (TIR), 
(TIR-NBS-LRR) (1).  It is believed that some R proteins are localized to the 
plasma membrane, consequently in close proximity to many types of Avr 
proteins, thus facilitating detection in the gene-for-gene hypothesis (44).  In the 
guard hypothesis, such localization would permit close monitoring of the 
guarded host proteins.  However, the biochemical means of transmitting a 
signal indicative of Avr protein recognition still remains a mystery for most R 
proteins.  Some R proteins, such as RSR-1, also contain WRKY domains and 
are postulated to enter the nucleus upon activation and facilitate defense-
4
Figure1.2. b o n1-1 has a temperature-
dependent growth defect (a).  PR1 (b) and 
EDS1 (c) are constitutively activated in 
bon1-1 plants grown at 220C. Gen. Dev 
(2001).  
 
related gene activation (10). Others, such as Pto have a Ser/Thr kinase 
domain and myristolation motif (32).  However, R proteins are only the start of 
the HR-signaling process.  Downstream of many TIR-NBS-LRR R proteins are 
several proteins that are critical for the activation of defense responses, some 
of which are dependent on salicylic acid (SA).  Among these are enhanced 
disease susceptibility 1 (EDS1), and phytoalexin deficient 4 (PAD4), so named 
for the phenotypes of their respective LOF alleles (11). Both of these genes 
code for lipase-like proteins and are positive regulators of SA, contributing to 
SA accumulation, which is important for signaling HR and triggering systemic 
acquired resistance.  Plant survival depends on tight regulation of these 
pathways as untimely activation or repression can compromise fitness and 
survival.
 Copines are an evolutionarily  conserved family of proteins and have 
been found in plants, worms, mice, and humans.  This protein family is 
characterized by  the presence of two C2 domains for calcium-dependent 
phospholipid binding, and an A domain.  The latter has sequence homology to 
the von Willebrand domain in integrin, possibly conferring protein-protein 
interactions between this copine and other proteins (45). One member of this 
family was identified during a screen for mutants with temperature-dependent 
growth defects in Arabidopsis (18).   The gene was cloned and named 
BONZAI 1 (BON1) for its temperature-dependent dwarfed phenotype (Figure 
1.2) caused by the recessive LOF allele (bon1-1).  This dwarfed phenotype is 
the result of significant growth defects in the plant during early development 
that continues even after entering the reproductive phase. (Figure 1.3). This 
protein has been shown to associate with the plasma membrane and it binds 
to phospholipids in a calcium-dependent manner (18).  There are two 
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additional BON genes in A. thaliana, however, BON1 has a dominant role over 
these other copines. The bon1-1 mutant exhibits microlesions but other BON 
family mutants do not.  There is an apparent functional redundancy in the 
gene family as the BON family knockdown has a lethal phenotype (45).
 It was later determined that these dwarfed bon1-1 plants exhibit 
increased resistance to disease and constitutive expression (Figure 1.2) of 
several downstream resistance-indicative genes, such as pathogenesis 
related 1 (PR1), are possible causes of the dwarf phenotype (19, 45).  It is 
possible that the compromised cell growth may be the result of reallocation of 
cellular resources, energetically  costly defensive measures, a combination of 
both, or other unknown factors.  Thus, it is likely that the biochemical 
processes of cell death and disease resistance may be intimately  connected to 
those of growth homeostasis.  The defense pathway is apparently sensitive to 
perturbation of the norm with regard to cellular metabolism, whether caused by 
6
Figure 1.3 Comparison of Col & 
Ws to their respective LOF bon1 
alleles after bolting. Gen. Dev 
(2001). 
biotic or abiotic factors, and necrotic lesions may result (18, 45). 
 As to how the BON genes mediate normal growth under standard growth 
conditions (see Methods) remains a mystery. The bon1-1-like phenotype has 
been observed in Col-0 but not in the Wassilewskija (specifically, Ws-2) 
accession (Figure 1.3).  The LOF allele bon1-2 in Ws-2 grows normally  and 
has no discernable enhancement in disease resistance over wild-type Ws-2. 
However, about four years ago, our lab reported a natural modifier of BON1 in 
the Col-0 accession (44).  This modifier was identified as the haplotype-
specific R gene, suppressor of npr1-1, constitutive1 (SNC1).  This gene codes 
for a TIR-NBS-LRR R protein.  In bon1-1, SNC1 has a higher activity causing 
the observed phenotype and enhanced disease resistance of bon1-1.  The 
LOF allele snc1-11 completely rescues the bon1-1 (Figure 1.4) and 
suppresses activation of defense-related genes caused by bon1-1.  SNC1 
functions in a defense-activating pathway involving SA, which positively feeds 
back to SNC1 expression.   The SNC1-mediated resistance is also sensitive to 
ambient temperature. How this R gene is subject to the modulation of BON1 
and how temperature modulates disease resistance are unknown.   
 The BON genes do not function alone in the roles of regulating cell death 
and normal growth.  Through in a Y2H assay, using BON1 as bait, we have 
identified a strongly interacting protein: BON1-associated protein 1 (BAP1). 
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Figure 1.4 LOF snc1-11 rescues bon1-1 
Yang and Hua (2004) The Plant Cell
We later identified a homolog of BAP1 on chromosome 2, At2g45760, and 
named it BAP2. The BAP proteins contain a single C2 domain but they have 
no A domain (42) and we have discovered that these proteins have an 
apparent functional redundancy.  The bap1-1 LOF mutant has a weak 
phenotype similar to bon1-1 (Figure1. 5) that can be rescued at 280C, whereas 
bap2-4 is always wild-type (not shown).  Interestingly, the double homozygous 
bap1-1bap2-4 plants are seedling lethal and cannot be rescued by higher 
temperatures.
 We have also shown that these two proteins also negatively regulate cell 
death (45, 46).  Double heterozygous plants exhibit increased cell death and 
ROS accumulation in comparison to Col-0, bap1-1, and bap2-4 plants (39). 
BON1, BAP1, and BAP2 have also been shown to suppress cell death in 
yeast stressed by H2O2 and delayed HR in A. thaliana and N. benthamiana 
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Figure 1.5. Comparison of Col-0, bap1, bap1/
+bap2 and bap1bap2/+  after bolting.  The 
phenotype of the double heterozygous plants is 
more severe than the single mutants.  bap2 (not 
shown) has a wild-type phenotype.
leaves.  When A. thaliana plants were challenged with avriulent strains of Pst 
DC3000 (avrRpm1, avrRpt2), suppression or strong delay of HR was seen in 
Col-0 plants that were co-infiltrated with p35S::BAP1 and p35S::BON1 as 
opposed to separate infiltrations.  Similar results were observed in N. 
benthamiana plants transiently  expressing the potato R protein (Rx) and its 
elicitor PVX coat protein (CP) (46) when co-infiltrated with p35S::BAP1 and 
p35S::BON1.  These results indicate these proteins are functional partners 
and that their overexpression can suppress cell death elicited by a number of 
biotic and abiotic factors.
 As with BON1, we have discovered a connection to R genes as the 
bap1-1 phenotype is mediated through SNC1 and can be rescued with the 
LOF allele snc1-11 (24, 45, 46).  bap1-1bap2-4 plants (hereon referred to as 
bap1bap2), however,  cannot be rescued by snc1-11 but can be rescued by 
the LOF alleles of EDS1 and PAD4 (Figure. 1.6).  This finding suggests that 
other proteins, or perhaps other R genes, are targets of the BAP proteins in 
addition to SNC1.  It is unknown if the relationship  between the BON and BAP 
9
Figure 1.6. Double homozygous  bap1bap2, is 
seedling lethal.  Crossing double heterozygous 
plants to pad4 or eds1 completely rescues 
bap1bap2, suggesting that activation of R genes 
occurs in the bap mutants.
gene families to R gene regulation is direct or not.  If the relationship  is direct, 
it is possible that the BAP genes may function in a larger protein complex 
regulating the activity of SNC1 and other R proteins, or they may function in 
separate, yet related metabolic pathways.  However, if the regulation of R 
genes is indirect, unknown proteins could function in monitoring the 
biochemical status of the BAP proteins, and this may prove to be another 
supporting example of the guard hypothesis (8, 20, 28).  Currently, the specific 
mechanism of regulation by BON1 on plant defense responses is unknown.  It 
is necessary to understand the specific role of this gene, biochemical activity 
of the protein, and what other genes function in this metabolic pathway to 
explain how and why the loss of BON1 and BAP function effect plant 
morphology and resistance so dramatically.  
10
CHAPTER 2:
Cloning and Characterization of EBO12
Introduction
 We are hypothesizing that there exist other molecules functioning 
together with BON1 and the BAPs in the negative regulation of plant cell 
death.  One research focus has been to investigate the role of new 
components in this regulation through a bon1 enhancer screen. We used the 
phenotypically wild-type bon1-2 line (Figure. 2.1) in the Ws-2 background to 
perform a sensitive enhancer screen.  We have seen that double mutants of 
the BON family cannot be rescued by snc1-11, but can be rescued by LOF 
alleles of EDS1 and PAD4 (45).  We believe that the lack of SNC1 in Ws-2 
could lead to the discovery of other R genes or other proteins that are in the 
BON1 pathway or in a parallel pathway regulating defense responses. 
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Figure 2.1 ebo12bon1-2 exhibits a strong 
growth defect phenotype and necrotic lesions 
at 22 0C.  By Dr. S. Yang.
Results
Isolation of a bon1-2 enhancer
 To identify additional components in the BON1 regulatory pathway, Dr. 
Shuhua Yang performed an enhancer screen by  activation tagging in bon1-2 
plants (38). One such enhancer was identified and named enhancer of bon1-2 
12, (ebo12) (Figure 2.1).   To establish that the mutant was a true enhancer of 
bon1, it was crossed to Ws to determine if the ebo12 phenotype was linked to 
bon1-2.  This was found to be the case as the strong phenotype is only 
present in bon1-2 plants. ebo12bon1-2 plants exhibit a bon1-like phenotype 
when grown under standard conditions (see Methods) and complete rescue at 
280C, indicative of temperature sensitivity. ebo12bon1-2 plants have leaves 
that are often small and convex, and have random necrotic lesions that are 
indicative of PCD.  Dr. S. Yang determined that ebo12bon1-2 is dominant over 
bon1-2 (Table 2.1). Roughly  3/16 of the F2 population from an ebo12bon1-2 x 
Table 2.1 Phenotypic and BASTA™ resistance
data for ebo12bon1-2 x bon1-2.  No wild-type
plants survived in F2, conf irming that the
ebo12 gene alone was segregating and the
mutation is dominant.
36
(36 BASTA™+)
14
(0 BASTA™+)F2
AllNoneF1
ebo12-likeWild-typeGeneration
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Ws-2 cross (Table 2.2) had an ebo12-like phenotype indicating the 
segregation of a dominant (ebo12) and a recessive gene (bon1-2). 
 The activation tagging vector, pSKI015, conveys resistance to the 
herbicide BASTA™.  To assess if the phenotype was T-DNA linked, the F2 
progeny from crosses to bon1-2 and Ws were sprayed to select for plants 
carrying the transgene.  All plants with ebo12-like phenotype were resistant to 
BASTA™, and some of the wild-type looking plants died (Tables 2.1 & 2.2). 
Wild-type looking plants resistant to BASTA™ were not bon1-2 as determined 
Table 2.2 Phenotypic and BASTA™
resistance data for ebo12bon1-2 x Ws
8
(8 BASTATM +)
93
(70 BASTATM +)F2
AllAllF1
ebo12-likeWild-typeGeneration
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Figure 2.2 Functional domains of the protein for At5g03700. 
The protein contains 3 putative domains.  The PAN/Apple 
domain is a component found in S-locus glycoproteins and 
S-receptor kinases.  Figure courtesy of SubCellular 
Proteomic Database (SUBA)
by genotyping. In conclusion, the ebo12 mutation is dominant, and the 
phenotype is bon1-2 dependent and T-DNA-linked.
Overexpression of proximal genes 
 As the enhancer phenotype type is associated with the T-DNA insertion, 
Dr. Yang determined the insertion locus of the specific T-DNA linked to ebo12 
phenotype.  This was accomplished with thermoasymmetrical interlaced 
polymerase chain reaction (TAIL-PCR) to identify the flanking regions of the T-
DNA inserts, followed by genotyping of ebo12 plants with primers for 
candidate loci to establish which T-DNA was phenotypically  linked.  To 
ascertain if the activation tagging was linked to ebo12 by altering gene 
expression, genes in close proximity to the T-DNA insert were tested via 
Northern blotting for significant changes in expression level. One particular T-
DNA insert was found to be linked to the ebo12bon1-2 phenotype and is 
inserted 923 bp  into the 3’ end of At5g03700.  This gene codes for a 428 
amino acid protein with three putative functional domains (Figure 2.5).  One of 
these domains is a PAN/Apple domain found in the S-locus glycoproteins and 
S-receptor kinases of plants.  Thus, we have temporarily named this allele 
srk1-1.  To determine whether or not the presence of this T-DNA influenced 
expression of nearby genes Dr. Yang performed a Northern blot on this mutant 
and compared it to Ws-2 and bon1-2 plants.  She determined that the 3’ end of 
the gene (about 600bp) is overexpressed, the 5’ end cannot be detected, and 
an aberrant transcript runs at approximately 5kb (Figure 2.3). By employing 
rapid amplification of cDNA ends (RACE)-PCR Dr. Hua identified the RNA 
transcripts from ebo12 to be a chimera of the T-DNA insert and the 3’ end of 
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the SRK-like gene, however, the full length of the larger transcripts has yet to 
be accounted for. The nearby gene, At5g03690, which codes for a putative 
fructose-bisphosphate aldolase, was also overexpressed in ebo12 plants, in 
comparison to Ws and bon1-2 controls (Figure 2.3). A downstream heat-shock 
factor (HSF3A), annotated At5g03720, did not show any change in expression 
(data not shown).
 To determine if overexpression of the 3’ end of the SRK gene could 
recapitulate the enhancer phenotype, Dr. Rena Shimizu engineered a 
35S:srk1-1 chimera construct based on the RACE-PCR sequence data into 
the pGREEN vector. The construct was transformed into bon1-2 plants.  We 
phenotyped more than 30 BASTA® resistant lines and no ebo12-like 
phenotype was observed. Overexpression of At5g03690 in bon1-2 plants did 
not confer an ebo12-like phenotype either. 
Enhanced cell death in ebo12bon1-2
 We have seen that bon1-1 causes increased cell death in plant tissues 
and accumulates ROS.  We suspected an increase cell death in ebo12 plants 
because the leaves consistently show necrotic lesions, possibly due to PCD. 
To determine if the bon1-2 enhancer was functioning in a similar manner to 
bon1-1, Dr. Shimizu stained ebo12bon1-2 to look for changes in cell death 
rate and increased H2O2 accumulation.  Trypan Blue staining revealed an 
increase in the number of dead cells in ebo12bon1-2 compared to Ws and 
bon1-2 (Figure 2.4).  This stain is impermeable to living cell membranes, thus 
it will permeate any damaged or dead cells, regardless of the cause. 
Diaminobenzidine (DAB) reacts with H2O2 and produces a reddish-brown 
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precipitate.  This staining revealed strong accumulation of brown precipitates, 
indicating that these tissues were also accumulating H2O2, similar to bon1-1 
(45). (Fig 2.5)   These stains also accumulated strongly around what appeared 
to be necrotic lesions on the ebo12bon1-2 leaves.  Taken together, these 
results indicate that the necrotic lesions and increased cell death in 
ebo12bon1-2 leaf tissues are likely due to H2O2 accumulation.
Map-based cloning
 In order to identify the gene responsible for the enhancer phenotype in 
ebo12bon1-2 we employed a number of approaches, including map-based 
cloning to narrow down the genetic region of interest and identify the EBO12 
gene.  ebo12-bon1-2 (Ws-2) plants were crossed to bon1-1snc1-11 (Col-0) 
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Figure 2.3 Northern blot of Ws, bon1-2, 
and ebo12bon1-2.  By Dr. S. Yang
and the F2 population was generated for mapping.  A hundred plants were 
genotyped for the presence of the T-DNA (srk1-1 allele) within the SRK gene 
and all mutant plants contained this T-DNA.   Therefore, the gene must be 
close to the T-DNA, within 1cM (250,000bp) of the T-DNA insertion site.  The 
same population was checked for recombination events using the 
markersCTR1 (in At5g03720) and nga249.  These markers confirmed that the 
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Figure 2.4 Trypan Blue staining of 
ebo12bon1-2 tissues indicates 
increased number of dead cells in 
comparison to Ws and bon-2. By Dr. 
Shimizu.
Figure 2.5 Comparison of DAB 
staining. Dr. Shimizu.
linkage to the ebo12 phenotype was located upstream and within about 1cM 
of CTR1.  According to current online databases, there are very few simple 
sequence length polymorphisms (SSLPs), derived cleaved amplified 
polymorphic sites (dCAPS) markers within this region of chromosome 5. 
Thus, single nucleotide polymorphism (SNP) and the single-feature 
polymorphism (SFP) databases would be useful to search for polymorphisms 
if we wish continue fine-mapping.
Reverse complementation 
 We have hypothesized that the ebo12 phenotype could be caused by  
the overexpression of genes close to the insertion locus of the T-DNA.  To test 
this hypothesis, we chose to overexpress wild-type genomic fragments of 
genes At5g03690 and chimera clone of srk1-1.  The chimera was designed to 
contain part of the T-DNA and the 3’ end of At5g03700, as seen from RACE-
PCR data. The expression of these clones was driven with a 35S  promoter but 
they did not confer an enhancer phenotype in bon1-2 plants.  We also 
attempted long fragment PCR amplification of this locus, but were 
unsuccessful.  Thus, we constructed a genomic library of ebo12bon1-2 with a 
complexity  of 105, which approximately covers the entire genome.  The 
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Figure 2.6 Site of ebo12 T-DNA insert.  Arrows 
indicate expression change in ebo12 plants.
purpose of this approach was to duplicate the correct mutant locus as closely 
as possible in order to best recapitulate the ebo12-bon1-2 phenotype. It is 
possible that other mutations exist in addition to the T-DNA of which we are 
currently unaware.  Clones that covered the srk1-1 locus were isolated from 
the ebo12 library  by genotyping individual plaques.  One positive clone was 
identified after screening the library  and it covers approximately 20kb, which 
encompasses the two candidate genes.  This fragment covers the entire 
srk1-1 allele and up to 500bp downstream of the intergenic (putative promoter) 
region, but does not extend to At5g03720. This fragment was cloned into the 
pGREEN-0230 binary vector and then transformed into bon1-2 plants. 
Transgenic plants in the T1 generation were selected for with a BASTA™ 
spray.  Of the 46 surviving plants, 7 have exhibited a weak ebo12-like 
phenotype at the 4-6 leaf stage.  Some of these plants have shown a convex 
leaf shape and sporadic lesions but not to the same extent as ebo12bon1-2 
plants (data not shown).  It is important to ascertain if the phenotype is true 
and stable thus, we must phenotype the T2 generation and perform a Northern 
Figure 2.7 Ws, bon1-2 and ebo12bon1-2 
plants (left) compared against plants carrying 
the srk1 chimera RNAi construct (right) after 
bolting.  L7 is second from the right.  
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blot to determine if the desired genes are expressing in a manner reminiscent 
of ebo12bon1-2.  
RNAi knockdown of candidate genes
  Since activation tagging was used to generate this enhancer line, we 
hypothesized that the overexpression of EBO12 gene is the cause the bon1-2 
enhancer phenotype.  To test the candidate genes, we used RNAi silencing to 
knockdown the expression of these genes to determine if suppression of 
specific transcripts could suppress the enhancer phenotype.  We made RNAi 
constructs in the binary  vector pFGC1008 to knockdown the transcripts of 
srk1-1, At5g03690, and an LTR-Gypsy retrotransposon sequence 100bp 
downstream of At5g03700.  The choice of these candidates gene was based 
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Figure 2.8 Ws, bon1-2 and ebo12bon1-2 
plants (top row) compared against plants 
carrying the srk1 chimera RNAi construct 
(bottom).  L7 on the bottom left, has some 
lesions but shows the most rescue.
on the Northern blot data.  Although no signal was detected on the Northern 
blot for the retrotransposon we chose to make an RNAi construct for it as well. 
25 lines were obtained for the srk1-1, 12 for the retrotransposon.  None of the 
RNAi lines for the retrotransposon rescued the phenotype (data not shown). 
Some of the lines showed partial rescue in the T1 generation but only one line, 
L7, showed consistent rescue in the T2 generation (Figure 2.7, 2.8).  We 
performed a Northern blot on Ws, bon1-2, ebo12bon1-2, and several RNAi 
lines (with and without rescue) to check the expression levels of our candidate 
genes.  Interestingly, the RNAi not only  suppressed the expression of the 3’ 
end of the srk1-1 allele, but also that of At5g03690.  This result was 
unexpected, but could be attributed to the fact that the RNAi construct 
contains part of the 35S sequence of the T-DNA.  Therefore, there might be 
additional effects of this particular RNAi construct on the expression of nearby 
genes.  Thus, we designed 2 more RNAi constructs to test this hypothesis, by 
targeting the 3’ end of At5g03700 and the 35S  promoter, specifically.  To 
expedite the cloning process, we switched to the pSUPER1300+ vector.  A 
total of 5 and 9 lines were obtained for the new constructs, respectively.  3 
lines showed partial rescue with the 3’ end specific RNAi in the T1 generation. 
In the T2 generation, no rescue was seen from these lines (Figure 2.9). To 
more conclusively determine if these KD constructs suppress the phenotype or 
not, more lines would be necessary in addition to RNA-blotting and probing of 
this locus to determine if the suppression has indeed occurred.
21
ebo12 single mutant analysis 
 The further understand the relationship  of EBO12 to BON1 we isolated 
the single mutant by crossing ebo12bon1-2 plants to Ws-2.  Homozygous 
ebo12 individuals were isolated and identified in the F2 generation by 
genotyping and BASTA® spray.   To determine the expression pattern of the 
candidate genes, we performed a Northern blot and probed for the 3’ end of 
srk1-1 and At5g03690 in Ws-2, bon1-2, ebo12bon1-2, and ebo12 plants.  The 
results indicated that the overexpression of the 3’ end of srk1-1 and 
At5g03690 was present in ebo12 plants as seen in ebo12bon1-2 but not Ws-2 
or bon1-2.  This supports the hypothesis that the T-DNA could be responsible 
for the overexpression of these transcripts and that the enhancer phenotype is 
dependent on the bon1-2 mutation. 
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Figure 2.9 srk1-1 3’end RNAi lines did not show 
rescue of ebo12bon1-2 phenotype.   
ebo12 has an enhanced basal disease resistance 
 To establish the connection of EBO12 to BON1 with respect to disease 
resistance, we investigated whether or not this enhancer influenced resistance 
to the bacterial pathogen Pseudomonas syringae pv. tomato DC3000. We 
determined that ebo12bon1-2 has enhanced disease resistance denoted by a 
substantial growth reduction in comparison to ebo12, bon1-2, and Ws-2 (Fig. 
2.12, 2.13). The results of the resistance assay indicate a synergistic effect on 
pathogen resistance between bon1-2 and ebo12, suggesting that these genes 
are in the same regulatory pathway.   Thus, the enhancer could be a true 
component in the BON1 signaling pathway. 
 Additionally, we tested whether the resistance phenotype is dependent 
on EDS1, which is an important signaling component downstream of many R 
genes.  These plants were crossed to eds1-1bon1-2 to determine if LOF EDS1 
allele could rescue the enhancer phenotype. (Figure 2.14). The 
ebo12bon1-2eds1-1 mutant plants were obtained and they exhibited a wild-
type phenotype and normal plant size comparable to Ws and bon1-2 under 
Figure 2.10 ebo12 does not exhibit a 
bon1-like phenotype.
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standard conditions.  The necrotic lesions that were apparent on the double 
mutant leaves were absent in the triple, indicating a reduction in PCD.  Thus, 
the enhancer gene could be in the same pathway as BON1 and EDS1 and lies 
upstream of the latter. 
 Enhanced basal disease resistance of ebo12bon1-2
As an enhancer of bon1-2 we expected the necrotic lesions and dwarfed 
stature of ebo12bon1-2 to be correlated a heighten state of disease 
resistance.  Preliminary data from Dr. Shimizu suggested a 102cfu mg-1 fresh 
weight decrease of DC3000 growth in ebo12bon1-2 in comparison to Ws-2 
and bon1-2 plants at 4 days-post inoculation.  To determine whether or not the 
interaction of bon1-2 and ebo12 is synergistic with respect to basal disease 
resistance, ebo12 plants were grown together with Ws-2, bon1-2, and 
ebo12bon1-2.  At 4 days post-inoculation (dpi), ebo12-bon1-2 showed about 
2.1x104cfu mg-1 fresh weight growth, approximately 100-fold less bacterial 
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Figure 2.11 Northern blot analysis of 
ebo12.  Overexpression of the two 
candidate genes is not affected by the 
bon1-2 mutation.
growth than Ws-2 and bon1-2 (6.4x106 and 9.9 x105cfu mg-1 fresh weight, 
respectively), consistent with previous findings (Figure 2.13).  ebo12 plants 
showed susceptibility to DC3000 (2.1x106cfu mg-1 fresh weight), comparable 
to bon1-2, indicating a synergistic effect of the two mutations on the basal 
disease resistance in the double mutants.  This suggests that the two genes 
could be functioning in parallel pathways governing the regulation of defense 
responses in A. thaliana.
 ebo12 function is mediated by eds1-1
     Because the defense-related genes PAD4 and EDS1 mediate the function 
of many R­-genes, we wanted to determine if this was also true for EBO12.  If 
the function of ebo12 is mediated through EDS1, then we would expect that 
the eds1-1 mutation would abolish the enhanced disease resistance of ebo12-
bon1-2.  Thus, ebo12bon1-2 plants were crossed to eds1-1bon1-2, and 
homozygous ebo12bon1-2eds1-1 plants (triple mutants) were isolated in the 
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Figure 2.12 Disease resistance assay of 
ebo12bon1-2 compared to bon1-2 and Ws.  By 
Dr. Shimizu.
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F2 generation (Figure 2.14).  To determine the relative resistance/susceptibility 
of these triple mutants, they were grown alongside Ws-2, bon1-2, eds1-1, 
eds1-1bon1-2, and ebo12bon1-2 plants.  As expected, eds1-1 and 
eds1-1bon1-2 (5.4 x107 and 8.3 x107 cfu mg-1 fresh weight, respectively) had 
greater susceptibility  to the pathogen at 4 days-post inoculation compared to 
Ws-2 (6.4 x106 cfu mg-1 fresh weight) (Figure 2.13).  Interestingly, the 
ebo12bon1-2eds1-1 plants were susceptible to the pathogen (5.2 x106 cfu 
mg-1 fresh weight), relative to Ws-2, bon1-2, and ebo12 plants.  Since these 
plants are more resistant than eds1-1 or eds1-1bon1-2, it is possible that the 
function of ebo12 is not completely mediated by EDS1.  Crosses have been 
made between ebo12bon1-2 plants and pad4-5 to ascertain the importance of 
PAD4 in EBO12 function. In bon1-1 and bap1bap2 plants the eds1 and pad4 
mutations also abolished the observed ROS production, noted by a reduction 
in DAB staining (45, 46).   It remains to be seen if this is also the case with 
ebo12bon1-2.
Discussion
 We report that ebo12 is an enhancer of bon1-2 and that its 
morphological phenotype and enhanced disease resistance are dependent on 
the T-DNA inserted into At5g03700 and the bon1-2 mutation. From Northern 
blot analysis of the single mutant we have seen that srk1-1 is sufficient to 
cause the overexpression of two neighboring genes, likely by the T-DNA.  It 
still remains to be seen if there are additional mutations linked to the 
phenotype.  At5g03700 is more strongly affected by  this T-DNA because only 
the 3’ end of the gene is expressed in addition to several aberrant transcripts. 
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The phenotype and disease resistance of ebo12 are dependent on bon1-2 as 
the single mutant, which lacks a bon1-like phenotype, is as susceptible to 
DC3000 as Ws-2.  These results indicate that there is a synergistic effect of 
ebo12 and bon1-2 with respect to phenotype, cell death, and disease 
resistance.  
 In an effort to conclusively  clone the EBO12, we have attempted to 
recapitulate the phenotype by cloning and overexpressing the gene 
candidates, the srk1-1 allele.  We have not seen ebo12-like phenotype with 
overexpressed srk1-1 chimera or At5g03690 which may suggest that neither 
of these genes is the true EBO12.  It is possible that there are additional 
mutations present that we are currently unaware of that are necessary to 
cause an ebo12 phenotype.  We are certain that a single T-DNA is linked to 
the phenotype due to numbers of BASTA™ resistant offspring of ebo12bon1-2 
x bon1-2 cross and TAIL-PCR, which identified only one linked T-DNA.  It is 
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Figure 2.13 Resistance to DC3000.  ebo12 double= ebo12bon1-2, 
ebo12 triple= edbo12bon1-2eds1-1.
important to note that this T-DNA was identified only  by  the right border.  We 
have not been successful with PCR-amplification of the left border.  The 
insertion of the T-DNA insert could have caused small insertion/deletion 
mutations.  Our srk1-1 chimera is an approximation of what we believe to be a 
prominent transcript in ebo12 plants. We have seen an unexplained larger 
transcript by Northern blot analysis in ebo12 and ebo12bon1-2 plants.  If this 
transcript is indeed necessary for the enhancer phenotype in bon1-2, perhaps 
we have not expressed all of the critical regions in srk1-1, which could account 
for a lack of recapitulation of the ebo12 phenotype.  
 To test this hypothesis, it was necessary to employ either large 
fragment PCR of the genomic DNA or isolation of a clone from a library of 
ebo12 plants such that the genetic conditions could be duplicated as closely 
as possible.  Preliminary data has suggested that the transformed genomic 
DNA clone encompassing this region may yield an ebo12-like phenotype. 
However, it is important to note that recapitulation of the phenotype with ebo12 
genomic DNA would only indicate whether or not we have the correct region 
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Figure 2.14 Rescue of ebo12bon1-2 by eds1-1. 
By. Dr. Shimizu.
isolated.  This would not be conclusive evidence to identify a specific gene, 
however, it could support cloning of a larger chimera construct.
 In another effort to identify the gene, we attempted to knockdown the 
overexpression of the candidates with RNAi.  We engineered an RNAi 
construct for the srk1-1 chimera and saw only  one line capable of rescuing the 
ebo12 phenotype.  In this line, both the aberrant transcripts of At5g03700 and 
overexpression of At5g03690 were suppressed.  A  reduction in expression 
levels was noted in other lines showing a weaker degree of rescue.  This could 
be a result of differential expression of the RNAi construct or efficiency  of the 
knockdown between independent transgenic lines. Suppression of At5g03690 
was unexpected as the srk1-1 chimera was not designed to target the 
expression of this gene.  It is possible that knocking down the T-DNA has a 
pleiotropic effect on gene expression, or perhaps this locus is under a more 
interconnected manner of gene regulation.   This data suggests that perhaps 
targeting the T-DNA, the 3’end of At5g03700, or both is sufficient to suppress 
the ebo12-like phenotype. 
 We have shown that the ebo12 mutant not only enhances a bon1 
morphological phenotype in Ws-2, but that these genes together, 
synergistically  enhancing the basal disease resistance of A. thaliana (Figure 
2.13).  bon1-2 and ebo12 alone do not confer resistance, but in concert these 
mutations cause the plants to exhibit 102 cfu mg-1 fresh weight less bacterial 
growth after 4 days.  The eds1-1 mutation abolishes the enhancer phenotype 
of ebo12bon1-2, but the disease resistance is only compromised to wild-type 
levels, not to those of eds1-1 mutants (Figure 2.12).  This suggests a partial 
mediation of ebo12 function through EDS1, which may suggest alternate 
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means of regulating defense responses and additional downstream 
components in the signaling pathway.
 To further understand the interaction of EBO12 and EDS1 in disease 
resistance, we could also investigate the ROS accumulation in these plants as 
well as the expression of other genes whose function is dependent on EDS1. 
We have seen that ROS accumulation occurs in ebo12bon1-2 leaves, a 
possible cause of necrotic lesions and heighten levels of cell death, and this 
may be affected by eds1-1.  Further RNA expression analysis of Ws, bon1-2, 
eds1-1, ebo12bon1-2, and ebo12bon1-2eds1-1 for other defense-related 
genes could enable us to determine what genes are still activated in 
ebo12bon1-2eds1-1 plants and may contribute to their relative resistance.  
 If the srk1-1 is the real cause of the ebo12bon1-2 phenotype, this may 
be a gain-of-function mutation for At5g03700.  The implication of this work is 
that a new method of regulating defense responses could be identified in a 
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Figure 2.15 Overexpression of the two candidate 
genes is dependent on the T-DNA in At5g03700. 
Expression is altered in L7 RNAi plants.  eds1-1 does 
not alter gene expression but rescues phenotype.  
gene that would not normally  have been suspected of such, based on its 
putative functional domains.  By using 5’ and 3’ end specific probes for 
At5g03700, the RNA-analysis has revealed that only the 3’end of this gene is 
overexpressed in ebo12 mutants (Figure 2.3).  The T-DNA is inserted at 923bp 
(amino 307), therefore only the PAN/Apple domain is expressed.  It is 
unknown what the normal function is for this protein and we have yet to 
determine if the overexpression of this portion of the gene is required for the 
enhancer phenotype.  If it is, we can speculate that perhaps this aberrant 
protein could have a greater activity than the wild-type, or it may altogether 
have a novel function which has a significant impact on cell death regulation.
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CHAPTER 3:
Structure & Function Analysis of BAP2
Introduction
  We have shown that the BAP gene family  function is essential in 
regulating cell death in plants and it can function as such in yeast (46). 
However, the molecular mechanism of this regulation and interacting proteins 
in addition to BON1 are currently unknown.  To answer questions regarding 
the molecular mechanism it is necessary to first understand the normal 
function, localization, and biochemical activities of these proteins.  It has been 
previously established that BON1 and BAP1 both bind to the phospholipids in 
a Ca2+-dependent manner (46).  However, we have yet to determine if BAP2 
binds in a similar manner or what the functional mechanism is of this protein. 
The research focus with this protein has been to determine the normal 
mechanism of function by mutagenesis of known functional domains.  We 
wished to answer the following questions: Does BAP2 also function in a Ca2+-
dependent manner? Which amino acids are essential for this function and 
alter the membrane binding affinity?  Is Ca2+-dependent phospholipid binding 
essential for normal cellular localization of this protein? With human cytosolic 
phospholipase A2, Bittova et al’ used specific mutations to identify which 
aspartates were important in coordinating Ca2+ ions (5).  Thus, we decided to 
mutate specific residues chosen by  protein domain alignment in the C2 
domain, and then test the functionality of the mutant protein by a 
complementation assay.  Once a non-functional mutant is identified, we will 
test if the protein is properly expressed and localized.
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Results
 Mutation of the C2 domain
 In order to ascertain if the C2 domain is important for the localization 
and function for BAP2, we chose to mutate highly conserved residues in this 
domain.  We aligned BON1, the BAP proteins, and human phospholipase 2 (5, 
46) and identified 2 conserved aspartate residues potentially  required for 
coordinating Ca2+ ligands. The native promoter of BAP2, though not 
specifically determined, was used to preserve the natural pattern of 
expression.  The utilized promoter region spans -1 to -1500 bp  in front of the 
start of the reading frame.  A 3HA tag was added to the N-terminus of the 
BAP2 protein with the start codon of BAP2 removed. The following two 
constructs were made: pBAP2:3HA-BAP2 (wild-type) and pBAP2:3HA-BAP2 
D38A, D88A (mutant).
 To determine if the mutated residues were important for the biological 
function of BAP2, we transformed these constructs into bap1/+bap2 plants 
and looked for phenotypic complementation.  It was also important to 
determine if BAP2 tagged with 3HA could function in vivo.  We chose this 
mutant because the bap2 single mutant does not exhibit an obvious
Figure 3.1 Alignment of BAP1 and BAP2. 
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 phenotype while bap1/+bap2 has a strong phenotype and bap1bap2 is lethal. 
If D38 and D88 were critical to the function of BAP2, then the mutant construct 
would not be able to complement the strong phenotype of bap1/+bap2 or 
bap1bap2.  We are assuming that the mutations made to BAP2 will not 
destabilize the protein nor cause major conformational changes. The 
pBAP2::3HA-BAP2 construct also served as a control of whether or not the 
expression level of the transgene expression is sufficient and that the fusion 
tag does not compromise BAP2 function.  A total of 52 total transgenic lines 
were obtained from floral dipping 4-week old bap1/+bap2 plants and selecting 
the transgenic seedlings on ½ MS hygromycin plates.  Due to the segregation 
of bap1 in this population, it was necessary to genotype the transgenic lines to 
determine whether the lines were bap1bap2, bap1/+bap2, or and BAP1bap2 
(Table 3.1).  A total of 28 plants with a bap1/+bap2 genotype were identified. 
All lines were checked in the T1-T3 generations for complementation. All 
plants with a BAP1bap2 genotype were wild-type regardless of the transgene 
they carried and therefore gave no information about the transgene 
functionality. The transgenic lines with the BAP2 transgene did not completely 
complement the bap1/+bap2 phenotype as expected (Fig. 3.2).  No double 
homozygotes were ever observed in T1; and 1/4 of the progeny of bap1/+bap2 
T1 plants did not germinate or survive the early seedling stage, regardless of 
the transgene.  17 lines with a bap1/+bap2 background carried the transgenic 
BAP2 and 10 of these exhibited variations in the degree of rescue (Figure 3.2). 
None of the 11bap1/+bap2 lines bearing the mutant BAP2 transgene showed 
any rescue at all.  Of the T1 plants with a bap1/+bap2 genotype, ¼ of their T2 
offspring also did not germinate. Thus, we concluded that the wild-type 3HA-
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BAP2 transgene is functional and it is possible that the two mutated amino 
acids are essential to normal protein function.
Detection of 3HA-BAP2 by Western Blotting
 To ascertain that the phenotypic rescue with the BAP2 transgene and 
lack thereof with the mutant was not due to a difference in expression level, 
we performed a Western blot on total protein extracts from multiple transgenic 
lines to detect the fusion protein.  Since the variability of the wild-type
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Figure 3.2 (a) T3 plants carrying the D38A D88A 
mutant transgene do not exhibit any phenotypic 
rescue. (b) T3 plants transformed with BAP2 
transgene exhibit varying degrees of rescue from 
none to complete.  Some plants have normal leaf 
morphology but display multiple inflorescent 
shoots at time of bolting. 
 
 transgene rescue was prevalent, we decided that the lines showing the 
strongest rescue should be used. We selected the lines carrying the mutant 
transgene at random. The total length of the coding region of the transgene is
 724 bp  so we expected to see protein signal at approximately 26 kDa. 
However, we could not detect any signal from the desired protein on a 
Western blot (data not shown).  The positive control for the Western blot 
primary antibody, BON1-3HA, was easily detected.  Since the expression of 
BAP2 is normally less than either BON1 or BAP1, we hypothesized that the 
protein is either not highly expressed, or it could be under a rapid turn-over. 
Thus, we attempted immunoprecipitation (IP) enrichment to enhance the 
signal from any present protein.  Unfortunately, the IGg bands of the 
monoclonal antibody run at ~50 and ~25kDa on the gel, thus their strong 
signal on the Western blot obscured any signal from the 3HA tag.  A longer 
runtime on the protein gel did not improve the resolution nor enable us to 
discern signal from the primary antibody or fusion protein.
 When expression of BAP2 protein could not be detected by Western 
blot of total protein or an IP-enriched extract, we decided that a stronger 
0 11 
(all mut) 
19 
(all wt) 
pBAP2::3HA-BAP2  
(mut) 
0 17 
(10 wt) 
5 
(all wt) 
pBAP2::3HA-BAP2  
(wt) 
bap1bap2 bap1/+bap2 
(phenotype) 
BAP1bap2 
(phenotype) 
Transgene 
Table 3.1 T1 data of pBAP2::3HA-BAP2 constructs 
transformed into bap1/+bap2 plants.  Rescue seen 
in 1/2 of plants bearing wild-type BAP2. No double 
homozygotes were found .  
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promoter should be used to drive the expression.  DIfficult detection with the 
BAP1 protein under its native promoter was also noted Dr. H. Yang and 
Yongqing Li.  They were able to detect the protein when they expressed 
35::MYC-BAP1 in N. benthamiana.  We therefore cloned the 3HA-BAP2 
transgene into the pSUPER 1300+ binary vector with a strong promoter and 
transformed the construct into GV3101 and C58C1 A. tumafaciens lines for 
generating stable transgenic lines in A. thaliana and transient expression in N. 
benthamiana, respectively.  Again, stable transgenic seedlings were identified 
on ½ MS hygromycin plates.   10 lines with BAP2 were identified and 34 with 
mutant transgene (Table 3.2).  Among these, 6 and 15 lines had a bap1/+bap2 
background, respectively (Table 3.2.). No bap1bap2 plants were identified and 
none of the lines bearing the mutant transgene showed any phenotypic 
rescue.  We noted some partial rescue with the BAP2 transgene, similar to 
what was seen in the other transgenic lines with the native BAP2 promoter. 
Transient expression in N. benthamiana
 Since the best detection of BAP1 was accomplished with transiently  
expressed 35S::MYC-BAP1 in N. benthamiana, we chose to employ this 
0 15 
(all mut) 
19 
(all wt) 
35S::3HA-BAP2  
(mut) 
0 6 
(2 wt) 
4 
(all wt) 
35S::3HA-BAP2  (wt) 
bap1bap2 bap1/+bap2 
(phenotype) 
BAP1bap2 
(phenotype) 
Transgene 
Table 3.2 T1 data of 35S::3HA-BAP2 constructs transformed 
into bap1/+bap2 plants.  Rescue seen in 1/3 of plants bearing 
wild-type BAP2. 
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strategy for BAP2 expression.  Two-month-old plants were infiltrated with 
sterile infiltration media (mock treatment), C58C1 cells carrying an empty 
vector, or the wild-type or mutant 3HA-BAP2 transgene.  Because the time of 
strongest expression of the transgene had yet to be determined, we collected 
tissue samples from the leaves at 2, 3, and 4 days post-infiltration.  Total 
protein was extracted and run on 12% polyacrylamide gels.  Western blotting 
revealed strong binding of the HA monoclonal antibody to a protein running at 
approximately  26 kDa.  This band was seen uniformly in all samples, 
regardless of the treatment.  Thus, this protein is likely an endogenous protein 
from N. benthamiana that the antibody binds to with sufficient affinity to be 
detected on the blot.  Concurrently, this band size is precisely the expected 
size of the expressed 3HA-BAP2 fusion protein and therefore could mask any 
Figure 3.3 GFP fluorescence 2 dpi, multiple 
layers (a), thin layer peel (b).  Exposure time 
0.5 sec.   
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signal from 3HA-BAP2 present in the samples.  Thus, further work with 3HA 
tags in N. benthamiana was discontinued.
BAP2 localization
 We subsequently fused a larger tag, GFP to BAP2 and expressed the 
fusion under the strong 35S  promoter.  The 35S::GFP-BAP2 construct in 
GV3101 was transformed into bap1/+bap2 to determine the functionality of the 
fusion protein.   The constructs in C58C1 A. tumafaciens were infiltrated into 
~2 month-old N. benthamiana plants.  To control for individual differences in 
the leaves an infiltrated spot of each of the following samples was made on 
the same leaf with a total of 4 leaves per trial: GFP alone, untransformed 
C58C1, wild-type and mutant GFP-BAP2.  Small samples of the spots were 
cut and examined under a compound fluorescence microscope at 2, 3, and 4 
days post-infiltration.  Days 2-4 post infiltration showed strong expression of 
GFP-alone and GFP-BAP2 wild-type and mutant.  Nothing beyond 
background fluorescence was observed at any time point for C58C1-infiltrated 
and untreated tissues (data not shown).  Continuous patches of cells exhibited 
GFP fluorescence 2 and 3 days post-infiltration in GFP-BAP2 infiltrated tissues 
(Figure 3.3).  GFP-only tissues showed ubiquitous cellular expression (Figure 
3.3).  GFP-BAP2 wild-type and mutant tissues did not fluoresce as strongly as 
GFP-only  but there appeared to be strong signal originating from the nucleus 
and plasma membrane of the cells.  Strongly  fluorescing tissues were 
collected for in vitro detection of GFP-BAP2 by  Western blotting.  GFP runs at 
approximately  26 kDa, BAP2 is expected to run at 23 kDa, thus we expected 
to find the fusion protein close to the 50 kDa standard band.  The GFP band 
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appears, as expected, between the 25 and 35 kDa standard markers (Figure 
3.4).  A  band running at 35 kDa is present in all samples and is therefore likely 
to be the result of non-specific binding of the monoclonal GFP antibody to an 
endogenous N. benthamiana protein (Figure 3.4).  Bands seen between 25-35 
kDa are also visible in lanes 6-9 and could be free GFP.  If these are true, a 
portion of the signal we’ve seen in the microscope could be partially  attributed 
to GFP and not GFP-BAP2.  A series of four bands between 50-40 kDa can be 
clearly  seen in lanes for GFP-BAP2 wild-type and mutant (2 and 3 dpi).  The 
smallest of these four appears to be shared in the GFP-only lane, thus might 
be background.  The others, however, (see arrow) appear to be unique to the 
GFP-BAP2-infilitrated tissues (Figure 3.4, lanes 6-9).  It is possible, although 
they run shorter than expected, that these bands could in fact be the GFP-
BAP2 fusion.  The difference in band intensity  between lanes 4 & 5, 6 & 8 
could be attributed to the higher expression of this fusion seen at 2 dpi, for this 
particular experimental run.  From these results, we know that the GFP-BAP2 
protein can be expressed and detected it by Western blotting. 
Figure 3.4 Western blot of GFP-BAP2 infiltrated in to N. 
benthamiana.  Lanes 2-3: C58C1 only, lanes 4-5: GFP only, 
lanes 6 & 8: GFP -BAP2 wt, lanes 7 & 9: GFP-BAP2 mut.  
Lanes 2, 4, 6, & 7, are 2dpi.  Lanes 3, 5, 8, & 9 are 3dpi. 
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 Because multiple layers of tissue can blur the specific protein 
localization in plant leaves, single layer peeling or protoplast expression can 
be better alternatives.  Single layer peeling revealed GFP-BAP2 mutant 
expressing tissues showing stronger signal in the nucleus, as opposed to 
ubiquitous expression in GFP-only expressing cells (Figure 3.3).  In tissues 
expressing wild-type GFP-BAP2, the nucleus was well-defined in the cells and 
the plasma membrane also had a strong fluorescent signal.  There appeared 
to be less fluorescence in the cytoplasm of these tissues.  However, these 
results may be due to either the true localization of BAP2 in the cells or the 
pattern could be due to overexpression and consequential mislocalization of 
the protein.
 Depending on the strength and flexibility  of individual leaves, single 
layer peeling is not always successful, thus, expression in A. thaliana 
protoplast cells provided another means of visualizing the protein localization. 
35S::GFP and 35S::GFP-BAP2 (wild-type and mutant) in the pSATC1 vector 
were transformed into A. thaliana  (Col-0) protoplasts by  Dr. Ying Zhu.  Strong 
fluorescent signal was detected in the GFP control, and the GFP-BAP2 wild-
type and mutant-transformed cells (Figure 3.5).  Expression of GFP under the 
35S promoter yielded strong fluorescence seen in both the nucleus and 
cytoplasm.  Some distinctive “network” fluorescence was also seen, which 
may be cytoskeletal (Figure 3.5).  In GFP-BAP2 transformed cells, the same 
fluorescent pattern was observed with addition of small dots scattered about 
the cytoplasm (Figure 3.5).  This was seen more often with the mutant 
transgene than the wild-type but it needs to be quantified.  These dots could 
be an artefact of the protein overexpression in these cells, and thus would be 
an inaccurate representation of native protein localization.  To determine if the 
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protein has been compartmentalized to specific organelles or vesicles, co-
expression with organelle or vesicle-specific markers labelled with other 
fluorescent tags would enable us to determine if there is any co-localization of 
the proteins.  
Discussion
Expressing and detecting BAP2
 We expected that introducing functional BAP2 protein would rescue 
bap1/+bap2 and bap1bap2 phenotypes in A. thaliana if the expression was 
appropriate and the 3HA tag did not impair normal function and localization. 
The rescue was only partial with BAP2 wild-type and varied between 
independent lines, however, no rescue was seen at all with the mutant BAP2. 
The variation with the wild-type transgene may be due to different levels of 
expression in each line.  Partial rescue may indicate that expression level and/
or pattern did not replicate those of the endogenous gene. Another 
explanation could be that the tag itself impairs normal function or destabilizes 
the protein; and it is not uncommon that tagged proteins can mislocalize, 
become unstable, or form aggregates in vivo (37).  Nevertheless, the wild-type 
tagged protein can partially rescue the bap1/+bap2 phenotype while the 
mutant tagged protein cannot. This evidence indicates that D23 and D88 are 
indeed important amino acids for the biological function of this protein. 
 To determine whether these mutations affect the biochemical activities 
or the stability of the BAP2 protein, we set out to compare the expression level 
and localization of the wild-type and the mutant BAP2 tagged proteins.  BAP1 
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was proven to be difficult to detect until it was expressed in N. benthamiana, 
driven with a 35S  promoter.  However, due to the non-specific binding of the 
HA antibody to an endogenous protein in N. benthamiana of similar molecular 
weight to 3HA-BAP2, we were unable to reliably distinguish these proteins. 
Although the wild-type BAP2 is capable of rescuing the bap1/+bap2 
phenotype to some extent, our attempts to detect the 3HA-BAP2 fusion protein 
were not very successful.  One possibility is that the fusion protein is not very 
stable and thus it degrades before we can probe for it on the Western blot. 
The GFP-BAP2 fusion appears to be more stable, therefore, stable transgenic 
lines bearing this construct may provide a more robust means of expressing 
and detecting the protein in vivo.  Additionally, the wild-type GFP-BAP2 may 
better rescue bap1/+bap2 plants and may perhaps even rescue bap1bap2. 
This would provide additional support for our conclusion that D23 and D88 are 
essential to BAP2 function and may indirectly indicate that the 3HA was 
interfering in the previous protein fusion.
 From expression and detection of the GFP-BAP2 fusion protein we 
found more than one band specific to GFP-BAP2.  By performing Western blot 
analysis on A. thaliana plants transformed with the GFP-BAP2 construct, we 
could confirm whether or not that these bands are real or background from N. 
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Figure 3.5 GFP-BAP2 fluorescence in Col-0 
protoplasts.   
 
benthamiana.  If these are real, this may suggest that some post-translational 
modification could be at work. The bands correspond to a mass less than we 
expected, but it is possible that different chemical modification, such as 
peptide cleavage and/or phosphorylation could have occurred.  To ascertain if 
such changes have occurred to the protein, we could attempt to purify the 
protein from the gel and do peptide finger printing mass-spectrometry on the 
bands to specifically  identify them.  In addition, treating the total protein 
extracts with phosphotases would remove phosphorlyation, if it has indeed 
occurred.  Mutagenesis would provide another means of identifying the 
necessity of specific post-translational modifications to protein function.  
 The preliminary data of GFP-BAP2 expression has shown that this 
protein fusion can be expressed and is stable enough for in vitro detection. 
However, it is too soon to conclude whether or not the D23AD88A  mutations 
we engineered in BAP2 have significantly influenced the in vivo protein 
localization.  It is possible that any differences between wild-type and mutant 
BAP2 localization may  have been obscured, due to overexpression by the 35S 
promoter.  It is equally possible that there is no alteration in protein localization 
although the biochemical activity  of the mutant protein has apparently  been 
compromised.  One means of circumventing potential complications of 
overexpression would be to use the native promoter of BAP2.  Using a weaker 
promoter may also determine if the GFP tag is causing any mislocalizing of the 
fusion protein due to its intrinsic chemical nature (37).    By using Ca2+ binding 
assays we should be able to better answer the question of whether or not this 
specific biochemical activity of the protein has been abolished.  It also remains 
to be seen if the putative C2 domain does indeed function normally  in Ca2+ 
44
binding and if these residues are components in the coordination of such 
cations.
  These findings could better enable us to understand the essential 
function of the BAP genes in the negative regulation of cell death in A. 
thaliana.  We have shown that the LOF alleles of these genes have a 
synergistic effect on cell death (46)  and we wish to determine how and why. 
We have seen with BON1 and BAP1 that certain functional domains are 
important to the biochemical activity and protein-protein interactions. Much 
remains to be uncovered with BAP2 with respect to its individual function. 
Evidently, BAP1 and BAP2 have overlapping functions, and it possible that 
they may function in a larger protein complex or in related molecular pathways 
in cell death regulation (46).  It also remains to be seen if the function of these 
genes with respect to cell death is direct or indirect.  If the latter is true, the 
strong cell death response in bap1/+bap2, bap1bap2/+, and bap1bap2 could 
be the result of “guarding” by specific R proteins, perhaps operating in a 
manner reminiscent of RPS2 and RPM1 on RIN4 (3, 4, 26).  By developing a 
deeper understanding of the BAP gene family function, we can better our 
understanding of the complex molecular mechanisms governing the intricacies 
of normal cell growth and plant defense responses.
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CHAPTER 4:
Perspectives
 We have shown that the BON and BAP gene families are essential to 
normal growth and development in A. thaliana.  Specific LOF mutants in these 
genes leads to increased ROS production, cell death, dwarfism, and 
constitutive activation of defense-related genes.  It is possible that the role of 
these proteins is a direct regulation of cell death by suppressing protein 
activity  and/or gene expression during plant development, a function perhaps 
independent of plant immunity.  However, we have seen that these proteins 
have an ancestral role in cell death regulation in other organisms (46). 
Therefore, it possible that these gene families are more closely  linked to innate 
immunity and therefore could be targets of effector proteins during pathogen 
infection.  If in accordance with the guard hypothesis, then R proteins may 
respond to the LOF mutations by constitutively activating basal defenses (8, 
20).  We have seen that combining LOF BON or BAP alleles results in more 
severe cell death phenotypes and that snc1-11 cannot fully rescue these 
plants(45, 46).  Thus, it is likely that other R genes are involved and have yet 
to be identified. Our enhancer screen in Ws-2 could lead to the identification of 
accession-specific defense signaling components because Ws-2 lacks SNC1. 
Thus, by uncovering additional components in the signaling pathway, and by 
understanding the molecular mechanism of the protein activity, we aim to 
answer the greater question of how these gene families function and their 
contribution to the delicate balance of defense activation, fitness, and survival. 
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METHODS
Growth Conditions
 All plants are vernalized at 40C for three days before germination in the 
growth facility.  Standard growth conditions include: constant light, 22 0C, 
30-70% relative humidity.  Metro Mix™ 220 and Redi Earth® topsoil were used 
as growth media.  1tsp Marathon® was applied to the flat trays during planting 
to repel aphids in all plants except those used for disease resistance assays.  
Genotyping
For amplifying the ebo12 T-DNA the following primers were used:  srk-2, 
35S-5
For amplifying of the wild-type sequence the following primers were used: 
srk-1, srk-2
SRK-2: agcaatcacagcaagcaaagaca
35S-5: cgtcttcaaagcaagtggattgatgtg
500-up primers are design to PCR-amplify the region downstream on 
At5g03700, encompassing the gypsy LTR retrotransposon.
500 up (rev): CCTTCCATttttggaaacttgaatc
500 up (for): cagtacatcaatgtatgtatacac
VRN2a GGGAGATTAAAGAAGCCTTTGC
VRN2b GTGCGGTTAACTGTTCGGTTACC
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Mapping Population
 This population is the F2 generation of crossing ebo12bon1-2 (Ws-2) to 
bon1-1snc1-11 (Col-0).  F1 plants were genotyped with VRN2 primers to 
ensure that crossing but not self-fertilization or contamination had occurred. 
TAIR, SNP, and SFP databases provide information for SSLP and DCAPS 
marker design.
Genomic Library Construction
 This process was derived from several protocols: Promega (phage 
vector source) Molecular Cloning Handbook (plaque lifts, phage amplification, 
screening, isolation), and Gan and Nasrallah labs (phage DNA prep). 
LambdaPhage vector: Lambda Dash II(a).  Host strain: XL1Blue (MRA) P2
RNAi Constructs
 The cloning adaptors were designed by Yongqing Li, based on 
information from the ChromDB website (www.chromdb.org).  The binary vector 
pFGC1008 (from Chromdb) with chloramphenicol and hygromycin selection 
was used.  Later constructs were cloned in pSUPER1300+ with Amp and 
hygromycin selection.
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Design of BAP2 transgenes
 The choice of residues to mutate was based on protein alignment in 
Vector NTI.  A fusion tag was added to determine the location of the protein. 
Other members of our lab have already done similar experiments with BON1 
and BAP1. Native promoter of BAP2 was to be used for determining the 
natural localization pattern. PCR was used to amplify a 1.5kbp  region in front 
of the 3’ UTR to encompass the promoter region.  A 3HA tag was added to the 
N-terminus of the protein.  The EcoR1 restriction site was employed to join 
pBAP2 and 3HA-BAP2 to complete the construct. Two constructs were made: 
pBAP2:3HA-BAP2  and pBAP2:3HA-BAP2 D41A, D87A. 
3HAsequence:
  TACCCATACGACGTTCCTGACTATGCGGGCTATCCCTATGACGTCCCGG
ACTAT GCAGGATCCTATCCATATGACGTTCCAGATTACGCTGCTCAG
construct primers: BAL TAABam: ccggatccagacggccgttgatacgc (adds BamH1 
site, removes TAA from BAP2)
BamH1-3HA for: GGGATCCCGTACCCATACGACGTTCCAGAC (adds BamH1 
site, removes ATG on the 5’ end of 3HA, specific to the 1st HA)
SpeI-TAA-3HA rev: GACTAGTCTTACTGAGCAGCGTAGTCTGGG (adds TAA 
onto the 3’ end of 3HA, specific to the 3rd HA)
NotI-ATG-BAP2 for: TTGCGGCCGCAAATGTCGTATTCAACATTC (adds NotI 
site on the front of BAP2)
Not1-3HA-BAP2 for: ttgcggccgcatgtacccatacgacgttccagac (installs Not1 site 
on 3’ end, for cloning 3HA-BAP2 into pBSK for mobilization into pFGC1008 so 
the gene fusion is under a 35S promoter).  The following vectors were used for 
constructing the transgene prior to cloning the completed version into 
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pCAMBIA-NOS (modified from pCAMBIA 1301 by  Dr. H. Yang): pBSK SK+/-, 
Promega pGEM®-T EASY Vector System I.  Plasmid DNA was prepared with 
Qiagen™ and Fermentas™ Miniprep kits.  DNA extraction from gels was done 
with the Wizard® SV Gel & PCR Clean-up System.
Southern, Northern, & Western blotting
 Samples were prepared with 0.1-0.15g of tissue with 2.5ml/1.0g protein 
grinding buffer.  Experiments done according to Molecular Cloning Handbook, 
2nd Edition, Vol1-2.  The monoclonal antibodies for the HA tag (HA.11 clone 
16B12) were synthesized and shipped to us from Convance™.  GFP primary 
antibodies suspended in 3% BSA in TTBS buffer instead of 2% milk.  
Immunoblotting
 3HA and GFP probing was done with monoclonal mouse antibodies 
from Covance™.  The secondary  antibody was an antimouse goat, also from 
Covance™.  Blots were washed 3 times for 20 min with TTBS (50mM Tris-HCl 
pH 7.5, 150mM NaCl, 0.1% Tween 20) in between blocking and antibody 
incubation.  ECL detection was accomplish by mixing 1:1 lab-made solutions 1 
& 2 which were stored @ 40C in the dark. 
Solution 1: H2O2, Tris-HCl pH 8.8
Solution 2: Tris-HCl pH 8.8, p-coumaric acid, luminol
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3HA-BAP2
 To mutate the chosen amino acids (D23, D88) to alanines, we used the 
Strategene® Quik Change® II XL kit to introduce site-specific mutations.
GFP-BAP2
 First, Dr. H. Yang cloned BAP2 into the pSATC1 vector.  We then 
mobilized the GFP containing cassette from pSATC1 by restriction enzyme 
digest with PI-psp1.  The insert was cloned into pHTP vector, also cut with the 
same enzyme and treated with CIP to prevent self-ligation.  Colonies were 
identified by  colony-PCR and then the 35S::GFP-BAP2 containing the pHTP 
binary vector were transformed into C58C1 or GV3101 A. tumafaciens lines.
Protein expression in E. coli
 Cloned 3HA-BAP2 wild-type and mutant from pGEM vector to pGEX5.1 
by cutting with EcoR1 and (?).  Constructs were sequenced using pGEX5.1 
primers as described in Strategene® manual.  Used BL21-DE3 cells from 
Strategene®, standard protocol.  Cells were grown overnight in LB+ Ampicillin 
media.  Then added to 50ml culture, 100-fold dilution.  Cells were grown to an 
OD600nm of 0.5 and then induced with 0.5 mM IPTG.  Measurements of cell 
growth were taken hourly and samples of pre and post-induction were saved 
for total protein gel.   All gels were 12% acrylamide.  
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